LeMaitre Vascular Inc.

Symbol: LMAT     Sector: Healthcare     Industry: Medical Instruments & Equipment

Dividend Yield
1.15%
Current Price
$29.44
Info     Dividend Rate History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
28,479,000
28,479,000
9,015,000
19,464,000
15,029,000
4,435,000
3,513,000
95,418,000
160,252,000
27,164,000
133,088,000
-
1,438,000
47,457,000
6,701,000
-
-
 
2,240,000

Financials 2018

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
28,389,000
28,389,000
9,171,000
19,218,000
13,623,000
5,595,000
6,025,000
94,017,000
153,088,000
22,853,000
130,235,000
26,318,000
-
47,986,000
-
6,525,000
6,571,000
 
2,347,000

Q 3

2018-09-30
24,165,000
24,165,000
6,910,000
17,255,000
12,642,000
4,613,000
4,314,000
86,810,000
144,327,000
18,980,000
125,347,000
20,104,000
-
45,626,000
-
583,000
4,308,000
 
2,037,000

Q 2

2018-06-30
27,020,000
27,020,000
8,028,000
18,992,000
13,327,000
5,665,000
8,751,000
92,364,000
137,100,000
16,356,000
120,744,000
19,638,000
-
52,936,000
-
-2,560,000
4,876,000
 
1,988,000

Q 1

2018-03-31
25,994,000
25,994,000
7,520,000
18,474,000
13,612,000
4,862,000
3,853,000
84,008,000
129,410,000
15,940,000
113,470,000
22,781,000
-
45,394,000
-
3,487,000
3,751,000
 
1,825,000

Financials 2017

Update: 2019-06-11 04:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
26,153,000
26,153,000
7,901,000
18,252,000
11,930,000
6,322,000
4,284,000
80,311,000
126,323,000
16,553,000
109,770,000
19,096,000
-
41,660,000
-
-18,474,000
6,770,000
 
1,583,000